NCT04985604 2025-10-02Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid TumorsDay One Biopharmaceuticals, Inc.Phase 2 Terminated23 enrolled 15 charts
NCT04704154 2025-04-18A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid TumorsBayerPhase 2 Completed175 enrolled 20 charts
NCT00091182 2013-06-05Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentNational Cancer Institute (NCI)Phase 2 Completed180 enrolled